{"title":"Stemona collinsiae 对十二指肠贾第虫的杀原虫活性。","authors":"Khuanchai Koompapong, Supaluk Popruk, Onrapak Reamtong, Tipparat Thiangtrongjit, Sumate Ampawong, Aurapa Sakulpanich, Ruenruetai Udonsom, Kanthinich Thima, Preeyaporn M Sreepian, Kittiyod Poovorawan, Hirotake Mori, Christen Rune Stensvold, Aongart Mahittikorn","doi":"10.1016/j.heliyon.2024.e41530","DOIUrl":null,"url":null,"abstract":"<p><p><i>Giardia duodenalis</i> is a major pathogen of the gastrointestinal tract, and infections impact both human health and the economy. The ongoing issues with drug resistance and the side effects of current anti-<i>Giardia</i> treatments highlight the urgent need for new therapeutic options. This study focused on investigating the <i>in vitro</i> efficacy of crude extracts of <i>Stemona collinsiae</i> from Thailand against <i>G. duodenalis</i>. <i>S. collinsiae</i> was initially extracted with hexane, followed sequentially by dichloromethane, ethanol, and water. The extracts were tested for growth inhibition against <i>G. duodenalis</i>. Dichloromethane and hexane extracts were highly active against the parasite after 48 h of exposure, with half-maximal inhibitory concentration (IC50) values of 60.77 μg/mL and 66.66 μg/mL, respectively. Both extracts reduced <i>G. duodenalis</i> trophozoite motility and adherence, altered trophozoite architecture, and induced apoptosis. Our findings demonstrate the anti-<i>Giardia</i> activity of <i>S. collinsiae</i> root extracts, especially those of dichloromethane and hexane. Our results will support the potential development of new and effective medications for the treatment of giardiasis.</p>","PeriodicalId":12894,"journal":{"name":"Heliyon","volume":"11 1","pages":"e41530"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761316/pdf/","citationCount":"0","resultStr":"{\"title\":\"Protozoocidal activity of <i>Stemona collinsiae</i> against <i>Giardia duodenalis</i>.\",\"authors\":\"Khuanchai Koompapong, Supaluk Popruk, Onrapak Reamtong, Tipparat Thiangtrongjit, Sumate Ampawong, Aurapa Sakulpanich, Ruenruetai Udonsom, Kanthinich Thima, Preeyaporn M Sreepian, Kittiyod Poovorawan, Hirotake Mori, Christen Rune Stensvold, Aongart Mahittikorn\",\"doi\":\"10.1016/j.heliyon.2024.e41530\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><i>Giardia duodenalis</i> is a major pathogen of the gastrointestinal tract, and infections impact both human health and the economy. The ongoing issues with drug resistance and the side effects of current anti-<i>Giardia</i> treatments highlight the urgent need for new therapeutic options. This study focused on investigating the <i>in vitro</i> efficacy of crude extracts of <i>Stemona collinsiae</i> from Thailand against <i>G. duodenalis</i>. <i>S. collinsiae</i> was initially extracted with hexane, followed sequentially by dichloromethane, ethanol, and water. The extracts were tested for growth inhibition against <i>G. duodenalis</i>. Dichloromethane and hexane extracts were highly active against the parasite after 48 h of exposure, with half-maximal inhibitory concentration (IC50) values of 60.77 μg/mL and 66.66 μg/mL, respectively. Both extracts reduced <i>G. duodenalis</i> trophozoite motility and adherence, altered trophozoite architecture, and induced apoptosis. Our findings demonstrate the anti-<i>Giardia</i> activity of <i>S. collinsiae</i> root extracts, especially those of dichloromethane and hexane. Our results will support the potential development of new and effective medications for the treatment of giardiasis.</p>\",\"PeriodicalId\":12894,\"journal\":{\"name\":\"Heliyon\",\"volume\":\"11 1\",\"pages\":\"e41530\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11761316/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heliyon\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1016/j.heliyon.2024.e41530\",\"RegionNum\":3,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/15 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heliyon","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1016/j.heliyon.2024.e41530","RegionNum":3,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
Protozoocidal activity of Stemona collinsiae against Giardia duodenalis.
Giardia duodenalis is a major pathogen of the gastrointestinal tract, and infections impact both human health and the economy. The ongoing issues with drug resistance and the side effects of current anti-Giardia treatments highlight the urgent need for new therapeutic options. This study focused on investigating the in vitro efficacy of crude extracts of Stemona collinsiae from Thailand against G. duodenalis. S. collinsiae was initially extracted with hexane, followed sequentially by dichloromethane, ethanol, and water. The extracts were tested for growth inhibition against G. duodenalis. Dichloromethane and hexane extracts were highly active against the parasite after 48 h of exposure, with half-maximal inhibitory concentration (IC50) values of 60.77 μg/mL and 66.66 μg/mL, respectively. Both extracts reduced G. duodenalis trophozoite motility and adherence, altered trophozoite architecture, and induced apoptosis. Our findings demonstrate the anti-Giardia activity of S. collinsiae root extracts, especially those of dichloromethane and hexane. Our results will support the potential development of new and effective medications for the treatment of giardiasis.
期刊介绍:
Heliyon is an all-science, open access journal that is part of the Cell Press family. Any paper reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards, will be considered for publication. Our growing team of dedicated section editors, along with our in-house team, handle your paper and manage the publication process end-to-end, giving your research the editorial support it deserves.